Lamotrigine Tablet
Product Images NDC 43063-203

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 43063-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063203 Label (43063203)

43063203 Label (43063203)
Label for Lamotrigine USP 100 mg tablets, containing 60 tablets per package. The medication is labeled and packaged by PD-Rx Pharmaceuticals, Inc., based in Oklahoma City, OK. The label includes the NDC number 43063-203-60, expiration date of 05/2021, and lot number I19A89. It also features medication warnings and fields for dosage instructions.*
FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 01

5a15187f B147 4147 A4ef 0e3e5de73cb6 01
Chemical structure of lamotrigine, showing a phenyl ring with two chlorine atoms and a triazine ring with two amino groups attached.*
FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 02

5a15187f B147 4147 A4ef 0e3e5de73cb6 02
A Kaplan-Meier curve showing failure probability (%) over weeks for Lamotrigine versus Placebo groups. The y-axis represents failure probability from 0% to 100%, and the x-axis represents time in weeks from 0 to 100. The graph includes censored data points marked with crosses for both treatment groups.*
FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 03

5a15187f B147 4147 A4ef 0e3e5de73cb6 03
A Kaplan-Meier survival curve chart displaying failure probability (%) over weeks (0 to 80). The graph compares two lines labeled "Placebo" and "Lamotrigine," showing failure probabilities increasing over time. Censored data points are marked with plus signs on both curves.*
FDA Label Image

708290c4 B959 47cc 95a1 38a6270297e5 1119 2

708290c4 B959 47cc 95a1 38a6270297e5 1119 2
Dimensional drawings of lamotrigine tablets showing upper and lower face imprints for strengths 25 mg, 100 mg, 150 mg, and 200 mg. Each strength has distinct markings on the upper face and scored or plain lower face, illustrating the physical appearance differences among these dosages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.